Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
Go back to Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion| Baxter International Inc. (NYSE: BAX) | Delayed: 23.37 -0.11 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.48 | 52 Week High | $50.16 | |||
| Open | $23.43 | 52 Week Low | $34.06 | |||
| Day High | $23.71 | P/E | 6.39 | |||
| Day Low | $23.20 | EPS | $3.66 | |||
| Volume | 6,568,961 | |||||
| CARLYLE GP (NASDAQ: CG) | Delayed: 40.03 +0.61 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.42 | 52 Week High | $18.40 | |||
| Open | $39.88 | 52 Week Low | $11.25 | |||
| Day High | $40.22 | P/E | 59.75 | |||
| Day Low | $39.41 | EPS | $0.67 | |||
| Volume | 2,039,910 | |||||
